Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
- 1 October 2006
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 70 (8), 1486-1494
- https://doi.org/10.1038/sj.ki.5001788
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the α1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate HomeostasisEndocrinology, 2004
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological PotencyJournal of Biological Chemistry, 2003
- Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturiaKidney International, 2001
- Post-transplant hypophosphatemiaKidney International, 2001
- Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalaciaProceedings of the National Academy of Sciences, 2001
- Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: Impact on muscular phosphate content, mineral metabolism, and acid/base homeostasisAmerican Journal of Kidney Diseases, 1999
- Prospective Study of Calcium Homeostasis after Renal TransplantationWorld Journal of Surgery, 1998
- EFFECT OF DAILY ORAL VITAMIN D AND CALCIUM THERAPY, HYPOPHOSPHATEMIA, AND ENDOGENOUS 1–25 DIHYDROXYCHOLECALCIFEROL ON PARATHYROID HORMONE AND PHOSPHATE WASTING IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormoneKidney International, 1981